SCHEMBL21974469

SCHEMBL21974469

CCn1c2c(c3ccccc31)C(=O)C(Cn1ccnc1C)CC2

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.78
KCNH2 Q12809 2/20 0.78
CYP1A2 P05177 1/20 0.78
CYP2D6 P10635 1/20 0.78
HTR3E A5X5Y0 1/20 0.78
SLC22A2 O15244 1/20 0.78
SLC22A1 O15245 1/20 0.78
SLC22A3 O75751 1/20 0.78
HTR3B O95264 1/20 0.78
CHRNB2 P17787 1/20 0.78
CHRNB4 P30926 1/20 0.78
CHRNA3 P32297 1/20 0.78
HTR2B P41595 1/20 0.78
CHRNA4 P43681 1/20 0.78
HTR3A P46098 1/20 0.78
HTR3D Q70Z44 1/20 0.78
SLC47A2 Q86VL8 1/20 0.78
HTR3C Q8WXA8 1/20 0.78
SLC47A1 Q96FL8 1/20 0.78
HDAC1 Q13547 6/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9834638 0.91 CYP3A4 (0.76) CYP3A4KCNH2CYP1A2CYP2D6HTR3E
Hydrochloric Acid SCHEMBL7407971 0.90 CYP3A4 (0.75) CYP3A4KCNH2CYP1A2CYP2D6HTR3E
SCHEMBL9835755 0.89 CYP3A4 (0.74) CYP3A4KCNH2CYP1A2CYP2D6HTR3E
SCHEMBL9837125 0.89 CYP3A4 (0.74) CYP3A4KCNH2CYP1A2CYP2D6HTR3E
SCHEMBL9837022 0.88 CYP3A4 (0.72) CYP3A4KCNH2CYP1A2CYP2D6HTR3E
SCHEMBL7408093 0.88 CYP3A4 (0.72) CYP3A4KCNH2CYP1A2CYP2D6HTR3E
SCHEMBL443444 0.88 CYP3A4 (0.72) CYP3A4KCNH2CYP1A2CYP2D6HTR3E
(R)-Ondansetron SCHEMBL848379 0.88 CYP3A4 (1.00) CYP3A4KCNH2CYP1A2CYP2D6HTR3E
(S)-Ondansetron SCHEMBL4543 0.88 CYP3A4 (1.00) CYP3A4KCNH2CYP1A2CYP2D6HTR3E
Ondansetron SCHEMBL1560211 0.88 CYP3A4 (1.00) CYP3A4KCNH2CYP1A2CYP2D6HTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200138964-A1 TERTIARY AMINE COMPOUND OR IMINE COMPOUND-POLYMER CONJUGATE AND PRODUCTION METHOD THEREFOR SEIKAGAKU CORPORATION (JP) 2020-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200138964-A1 TERTIARY AMINE COMPOUND OR IMINE COMPOUND-POLYMER CONJUGATE AND PRODUCTION METHOD THEREFOR SOAT1, SLC7A1, ODC1 CYP3A4 1037/4885KCNH2 1160/4885CYP1A2 2394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.